A Retrospective Observational Cohort Study on the Success of Non-Invasive Respiratory Support (NIRS) Treatments and the Factors Affecting the Success of NIRS in Coronavirus Disease-Related Acute Respiratory Distress Syndrome (ARDS)

Yıl 2025, Cilt: 9 Sayı: 3, 310 - 316, 22.12.2025

Zeynep Köylü Mızrak , Umut Sabri Kasapoğlu Mesut Öterkuş , Feyza İnceoğlu

https://doi.org/10.46332/aemj.1679163

Öz

Purpose: Non-invasive respiratory therapy is widely used as an important part of treatment in severe cases. We aimed to determine the factors affecting the success of NIRS in Covid-19-related acute respiratory distress syndrome cases.

Materials and Methods: 209 patients with severe Covid-19 infection who were hospitalised in the intensive care unit of our hospital between August 2020 and May 2021 were included in the study. The patients’ demographic information, Acute Physiology and Chronic Health Evaluation-II (APACHE-II) and Sequential Organ Failure Assessment (SOFA) scores, heart rates, acidosis, consciousness, oxygenation, respiratory rates and laboratory results were recorded and analysed.

Results: Advanced age, HT, chronic obstructive pulmonary disease, high APACHE and SOFA scores, low albumin levels, high LDH levels, and low PaO2/FiO2 were found to be the factors that reduced NIRS success. Additionally, we determined that low PaO2/FiO2 and SatO2 and blood PH increased early-stage failure.

Conclusion: Our findings suggest that NIRS can be an effective treatment method for Covid-19 patients and that NIRS applied in the early stages of the disease can reduce the risk of intubation and mortality.

Anahtar Kelimeler

coronavirus disease , non-invasive mechanical ventilation , respiratory distress

Etik Beyan

This study was approved by the Malatya Turgut Özal University Clinical Research Ethics Committee (dated 03.10.2021 and numbered 2021/84).

Koronavirüs Hastalığıyla İlgili Akut Solunum Yetmezliği Sendromu'nda Non İnvaziv Solunum Desteği Tedavilerinin Başarısı ve NIRS'nin Başarısını Etkileyen Faktörler Üzerine Retrospektif Gözlemsel Kohort Bir Çalışma

Öz

Amaç: Non-İnvaziv solunum desteği, şiddetli vakalarda tedavinin önemli bir parçası olarak yaygın olarak kullanılmaktadır. Covid-19ile ilişkili Akut Solunum Sıkıntısı Sendromu vakalarında NIRS'nin başarısını etkileyen faktörleri belirlemeyi amaçladık.

AraçlarveYöntem: Ağustos 2020 ile Mayıs 2021 tarihleri arasında hastanemizin yoğun bakım ünitesinde yatan şiddetli Covid-19enfeksiyonu olan 209 hasta çalışmaya dahil edildi. Hastaların demografik bilgileri, Akut Fizyoloji ve Kronik Sağlık DeğerlendirmesiII (APACHE-II) ve Sıralı Organ Yetmezliği Değerlendirmesi (SOFA) skorları, kalp hızları, asidoz, bilinç, oksijenasyon, solunum hızları ve laboratuvar sonuçları kaydedildi ve analiz edildi.

Bulgular: İleri yaş, HT, kronik obstrüktif akciğer hastalığı, yüksek APACHE ve SOFA skorları, düşük albümin seviyeleri, yüksek LDH seviyeleri ve düşük PaO2/FiO2'nin NIRS başarısını azaltan faktörler olduğu bulundu. Ek olarak, düşük PaO2/FiO2 ve SatO2 ve kan Ph'ının erken evre başarısızlığını artırdığını belirledik.

Sonuç: SonuçlarımızNIRS'nin Covid-19 hastaları için etkili bir tedavi yöntemi olabileceğinive hastalığınerken evrelerinde uygulanan NIRS'nin entübasyon ve mortalite riskini azaltabileceğini göstermiştir.

Anahtar Kelimeler

coronavirüs hastalığı , invaziv olmayan mekanik ventilasyon , solunum sıkıntısı

Etik Beyan

Bu çalışma, Malatya Turgut Özal Üniversitesi Klinik Araştırma Etik Kurulu tarafından onaylanmıştır (tarih 03.10.2021 ve numara 2021/84).

Kaynakça

• 1. WHO Interim guidance 2020. Clinical manage-ment of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. WHO/nCov/Clinical/2020.5 Available from: https://www.who.int/publications/i/item/clinical-management-of covid-19 Accessed 23 October, 2020.
• 2. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective co-hort study. Lancet 2020;395(10229):1054-1062.
• 3. Yang X, Yu Y, Xu J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecen-tered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481.
• 4. Wang Y, Lu X, Li Y et al. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020;201(11):1430-1434.
• 5. Grasselli G, Zangrillo A, Zanella A et al. Baseline characteristics and outcomes of 1591 patients in-fected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574-1581.
• 6. Zhao H, Wang H, Sun F, Lyu S, An Y. High-flow nasal cannula oxygen therapy is superior to con-ventional oxygen therapy but not to noninvasive mechanical ventilation on intubation rate: a sys-tematic review and meta-analysis. Crit Care. 2017;21:1-12.
• 7. Widyastuti Y, Zaki WA, Widodo U, Jufan AY, Pratomo BY. Predictive accuracy of the APACHE IV scores on mortality and prolonged stay in the intensive care unit of Dr Sardjito Hospital. Med J Malaysia. 2022;77(1):53-58.
• 8. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Prob-lems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707-710.
• 9. Ozyilmaz E, Ugurlu AO, Nava S. Timing of non-invasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulm Med. 2014;14:1-10.
• 10. Windisch W, Weber-Carstens S, Kluge S, Rossaint R, Welte T, Karagiannidis C. Invasive and Non-Invasive Ventilation in Patients With COVID-19. Dtsch Arztebl Int. 2020;117(31-32):528-533.
• 11. Delen LA, Öterkus M. Sinovac vaccination and the course of COVID-19 disease in hospitalized patients in Turkey. Ann Saudi Med. 2022;42(3):147-154.
• 12. Cammarota G, Esposito T, Azzolina D et al. Non-invasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis. Crit Care. 202130;25(1):268.
• 13. Ling L, Jianfeng X, Wenjuan W et al A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study. Lancet Digit Health 2021;3(3):166-174.
• 14. Guia MF, Boléo-Tomé JP, Imitazione P et al. Usefulness of the HACOR score in predicting success of CPAP in COVID-19-related hypox-emia. Respir Med. 2021;187:106550.
• 15. Ding M, Han X, Bai L, Huang S, Duan J. Impact of HACOR Score on Noninvasive Ventilation Failure in Non-COPD Patients with Acute-on-Chronic Respiratory Failure. Can Respir J. 2021;2021(1):9960667.